Not applicableStudy completedNCT02601547What this trial is testingPET-based Evaluation of Chemotherapy-induced Brain Damage in LymphomaWho this might be right forLymphoma University Hospital, Toulouse 18
Not applicableUnknownNCT05982626What this trial is testingStudy of 68Ga /131I SGMIB-ZT-199 PET Imaging Targeting HER2-positive in the Diagnosis of Metastatic Breast CancerWho this might be right forHER2-positive Breast Cancer Huashan Hospital 10
Testing effectiveness (Phase 2)Looking for participantsNCT04235114What this trial is testingEvaluation of 89Zr-DFO-nimotuzumab for Non-invasive Imaging of EGFR+ Cancers by Positron Emission Tomography (PET)Who this might be right forLung CancerColorectal Cancer University of Saskatchewan 14
Testing effectiveness (Phase 2)Study completedNCT00559377What this trial is testingFDG and FMISO PET Hypoxia Evaluation in Cervical CancerWho this might be right forCervical AdenocarcinomaCervical Squamous Cell CarcinomaStage IB Cervical Cancer+5 more National Cancer Institute (NCI) 16
Early research (Phase 1)Ended earlyNCT05638334What this trial is testingImmuno-positron Emission Tomography Study of 89Zr-S095012 in Patients With Advanced Solid TumoursWho this might be right forAdvanced Solid Tumor Institut de Recherches Internationales Servier 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT07059832What this trial is testingApplication of 68Ga-NODAGA-SNA006 Positron Emission Tomography/Computed Tomography (PET/CT) in TumorsWho this might be right forCancer First Hospital of China Medical University 30
Testing effectiveness (Phase 2)Looking for participantsNCT06408116What this trial is testingPredicting Esophageal Cancer Borders Using PET-ImagingWho this might be right forEsophagus Cancer, Stage IEsophagus Cancer, Stage II University Hospital Heidelberg 30
Not applicableStudy completedNCT01992016What this trial is testingA Pilot Study to Enhance F18 FDG-PET Imaging of Prostate Cancers With the Metabolic Inhibitor RanolazineWho this might be right forAdenocarcinoma of the ProstateBone MetastasesSoft Tissue Metastases+4 more University of Colorado, Denver 11
Not applicableStudy completedNCT01261598What this trial is testingPredictive Value of FDG-TEP During Radiotherapy or Chemo-radiotherapy in Patients With NCSC on the One-year SurvivalWho this might be right forLung CancerNSCLC Centre Henri Becquerel 98
Early research (Phase 1)Study completedNCT03242993What this trial is testing[18F]-AZAFOL AS POSITRON EMISSION TOMOGRAPHY (PET) TRACER in FR Positive Cancer ImagingWho this might be right forMetastatic Cancer LungMetastatic Ovarian Cancer University of Lausanne Hospitals 15
Not applicableEnded earlyNCT03619044What this trial is testingThe Use of FES-PET Imaging as a Tool to Detect a Possible Reversion of Estrogen Receptor (ER)-α Status in Patients With Metastatic Breast Cancer HER2 + and ERα Neg Treated With Trastuzumab + Pertuzumab + Taxane.Who this might be right forHER2-positive Breast Cancer Institut Claudius Regaud 4
Early research (Phase 1)Looking for participantsNCT03647358What this trial is testingLesion Dosimetry With Iodine-124 in Metastatic Thyroid CarcinomaWho this might be right forThyroid CarcinomaMetastatic Thyroid Carcinoma Memorial Sloan Kettering Cancer Center 75
Not applicableStudy completedNCT01663753What this trial is testingDiagnostic Performance of 18F-FDG-PET and Diffusion-weighted MRI in the Assessment of Stage IB to IIB2 Cervical Squamous-cell Carcinoma Response to Concomitant Radiochemotherapy and BrachytherapyWho this might be right forCancer of the Uterine Cervix Hospices Civils de Lyon 146
Not applicableStudy completedNCT01020097What this trial is testingFluorine F 18 EF5 Positron Emission Tomography in Assessing Hypoxia in Patients With Newly Diagnosed Stage I, Stage II, Stage III, or Stage IV Head or Neck Squamous Cell Cancer of the Oral Cavity, Oropharynx, and LarynxWho this might be right forSquamous Cell Carcinoma Abramson Cancer Center at Penn Medicine 5
Not applicableEnded earlyNCT00901303What this trial is testingPilot Study of Abbreviated Chemotherapy Based on Positron Emission Tomography (PET) Scan in Hodgkin's LymphomaWho this might be right forHodgkin's Lymphoma Weill Medical College of Cornell University 6
Testing effectiveness (Phase 2)Study completedNCT00855894What this trial is testingThe Combination of Erlotinib and Pertuzumab in Patients With Relapsed Non-small Cell Lung CancerWho this might be right forNon-Small Cell Lung Cancer Genentech, Inc. 41
Not applicableStudy completedNCT00256490What this trial is testingEarly Evaluation of the Response of Large B Cell Non Hodgkin's Lymphoma to Chemotherapy by PET/CTWho this might be right forLymphoma, Large-Cell Eric Turcotte 82
Very early researchStudy completedNCT05871320What this trial is testingNovel 99mTc-labeled Somatostatin Antaginosts in the Diagnostic Algotithm of Neuroendocrine NeoplasmsWho this might be right forNeuroendocrine Tumors Jagiellonian University 10
Testing effectiveness (Phase 2)Looking for participantsNCT05518903What this trial is testingInvestigational Scan (68Ga-FAPI-46 PET/CT) for Imaging of Cancer-Associated Fibroblasts for Localized Pancreatic Ductal AdenocarcinomaWho this might be right forLocalized Pancreatic AdenocarcinomaResectable Pancreatic Ductal AdenocarcinomaStage 0 Pancreatic Cancer AJCC v8+2 more Mayo Clinic 130
Early research (Phase 1)Not Yet RecruitingNCT07664397What this trial is testingImaging Study of [89Zr]DFO-YS5 for Cancer DetectionWho this might be right forBladder CancerNerve Sheath TumorNerve Sheath Tumors+9 more Robert Flavell, MD, PhD 40